Navigation Links
Jump-starting T Cells In Skin Cancer

Advanced melanoma, the most deadly form of skin cancer, can be successfully treated in some cases by vaccinating patients with tumor proteins. How these vaccines work and why they are only effective in some patients remains unclear. Pierre Coulie and colleagues now show, in two articles in the January 17 issue of the Journal of Experimental Medicine, that these vaccines work by increasing the number of immune cells called killer T cells that can attack the tumor. In an unexpected finding, however, they discovered that that these cells mostly recognize tumor proteins that were not contained in the vaccine. Understanding the characteristics of the T cell populations that are expanded after vaccination may help in the development of more effective anti-tumor vaccines.

Tumor-specific T cells can be detected in the blood and the tumors of many melanoma patients, and yet these cells are unable to kill the tumor. What causes the impotence of these T cells is a mystery. Equally mysterious is why vaccination against tumor-specific proteins sometimes causes tumor regression without expanding large numbers of vaccine-specific killer T cells.

Pierre Coulie's group studied anti-tumor T cells in patients vaccinated with a tumor antigen called MAGE-3. In one patient whose tumor regressed after vaccination, the authors found significantly more T cells specific for non-vaccine tumor proteins than were detected before vaccination. Vaccine-specific T cells, on the other hand, became detectable but did not expand to large numbers. Thus, reinvigoration of existing tumor-specific T cells after vaccination did not require large numbers of vaccine-specific T cells.

Although it is not known how these tumor-specific cells get activated, Coulie thinks that the few T cells stimulated by the vaccine may change the local, suppressive environment of the tumor such that other T cells can snap out of their stupor and attack the tumor.


'"/>

Source:Journal of Experimental Medecine


Page: 1

Related biology news :

1. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
2. Transplantation Of Monkey Embryonic Stem Cells Reverses Parkinson Disease In Primates
3. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
4. Weill Cornell Research Reveals Secrets Of Trafficking Within Cells
5. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
6. Placenta Is A Rich Source Of Blood Stem Cells
7. UCSD Discovery Shows How Embryonic Stem Cells Perform Quality Control Inspections
8. Estrogen-like Component of Plastic Stimulates Growth of Certain Prostate Cancer Cells
9. Protein That Promotes Survival Of Stem Cells Might Be Key To Poor Leukemia Prognosis
10. Infants With Rare Genetic Disease Saved by Cord Blood Stem Cells
11. Human Cells Filmed Instantly Messaging for First Time
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/1/2018)... ... ... Lecomte is hard at work on his second ocean crossing. After becoming the first human ... Tokyo to San Francisco, churning his limbs eight hours a day in the cold Pacific ... of its kind, The Swim is far more than just an extreme sport. Besides the ...
(Date:8/31/2018)... ... August 30, 2018 , ... CallTower is pleased ... more than 20-years of telecommunications experience and over ten years in executive leadership. Prior ... acquired by CallTower in early 2018. , In this new role, Jason ...
(Date:8/31/2018)... ... August 30, 2018 , ... Vinita Madill, space operations ... materials engineer, LightPath Technologies. In the future, these names may be as recognized ... birthday. Today, they are among 26 scientists whose work and words are showcased ...
Breaking Biology News(10 mins):
(Date:8/31/2018)... ... August 29, 2018 , ... A ... University of Southampton and the Institute of Industrial Science, the University of Tokyo, ... dramatically accelerate the exploration and study of hard to reach deep sea ecosystems, ...
(Date:8/29/2018)... ... August 28, 2018 , ... Nanovis , ... the successful completion of a $5.5 million funding round managed by Commenda Securities. ... Commenda Capital, and Ellipsis Ventures. , “Our investment in Nanovis is consistent with ...
(Date:8/29/2018)... (PRWEB) , ... August 28, 2018 , ... ... online retailer of contact lenses, has been ranked in 1138th place on the ... private companies. , The list represents the most successful companies within the ...
(Date:8/29/2018)... ... ... LabRoots , the leading provider of interactive virtual events for tech ... of a new gamification feature, allowing users to earn points by participating in the ... shirts. , Throughout each month, LabRoots users will earn points by building their profile, ...
Breaking Biology Technology: